A few months ago, we introduced you to a Mass General Brigham patient named Joe Walsh. Joe is the first patient to receive foralumab, a nasal spray that treats Alzheimer's disease by reducing inflammation in the brain. Since his treatment began six months ago, Joe's thinking and memory have been regularly evaluated by neurologists, one of whom is Howard Weiner, MD. His wife, Karen, thinks the novel drug shows promise, explaining that while he still has difficulty recalling words, he's become more engaged in social activities. Hear about Joe's journey with NPR: http://spklr.io/6185huJP (fb)

"If you use tobacco-containing products, your back health is another good reason to stop," says Jason Bessey, MD, an orthopedic spine surgeon. Learn more about our orthopedic services at Salem Hospital. http://spklr.io/6185hDEf (fb)